Good science relies on being open to new findings and changing ones approach based on new information. The subject of Senolytics is another such example where it has the potential to be beneficial but could also prove to be detrimental too. This is one of the reasons why the MMTP is testing Senolytics in robust lifespan testing to explore the possibilities of this new medical approach and to see if it has positive or negative effects or perhaps both. As part of our ongoing research we will be asking these kinds of questions so that we can proceed fairly and in an unbiased scientific manner, this is a cornerstone of our project and a primary reason why all our research data will be made open access and publicly available to all.
This interesting recent paper poses a similar question: